Authors: Ansevin, CF

Citation: Cf. Ansevin, Treatment of ALS with pleconaril, NEUROLOGY, 56(5), 2001, pp. 691-692

Authors: Ansevin, CF

Citation: Cf. Ansevin, Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability, NEUROLOGY, 55(3), 2000, pp. 458-458

Authors: Ansevin, CF

Citation: Cf. Ansevin, Phenotypic variability in rippling muscle disease, NEUROLOGY, 54(1), 2000, pp. 273-273

Authors: Muller-Felber, W Ansevin, CF Ricker, K Muller-Jenssen, A Topfer, M Goebel, HH Pongratz, DE

Citation: W. Muller-felber et al., Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis, NEUROMUSC D, 9(8), 1999, pp. 604-607

Authors: Walker, GR Watkins, T Ansevin, CF

Citation: Gr. Walker et al., Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: Possible relationship of antigens and stretch-activated ion channels, BIOC BIOP R, 264(2), 1999, pp. 430-435